India, Aug. 6 -- Today's top gainers in the biotech space include Creative Medical, boosted by a new U.S. patent covering exosome-based immunotherapy for Type 1 diabetes; Braveheart, following its IPO; Iovance, after reporting a 66% increase in second-quarter revenue; and Sight Sciences, after raising its full-year outlook following strong quarterly performance, among others.
Read on...
CELZ's Patent Expansion Sparks Investor Interest
Creative Medical Technology Holdings Inc. (CELZ) led the pack of gainers on Thursday, with shares rising more than 70% on patent news.
This clinical-stage biotechnology company advancing regenerative medicine solutions announced it has received a new U.S. patent covering exosome-based immunotherapy for Typ...